A Prospective Study on the Treatment of cLM Based on ICG Imaging
NCT ID: NCT06275022
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
110 participants
INTERVENTIONAL
2023-01-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will receive indocyanine green-fluorescence imaging before operation, while the patients in control group will receive traditional operation.
Researchers will compare difference in curative effect between two groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Indocyanine Green (ICG) Guided Tumor Resection
NCT04084067
Optical Tomographic Imaging of Infantile Hemangiomas
NCT01673971
Development of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations
NCT03440827
Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
NCT00374335
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
NCT05645523
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Macro/mixed cystic lymphatic A
Inflow occlusion assisted by indocyanine green-fluorescence imaging combined with perforation of septation and sclerotherapy
Inflow occlusion with perforation of septation and sclerotherapy
Inflow occlusion assisted by indocyanine green-fluorescence imaging combined with perforation of septation and sclerotherapy
Macro/mixed cystic lymphatic B
Perforation of septation and sclerotherapy
Perforation of septation and sclerotherapy
Perforation of septation and sclerotherapy
Microcystic lymphatic A
Indocyanine green-fluorescence imaging-guided partial resection and sclerotherapy
Indocyanine green-guided partial resection and sclerotherapy
Indocyanine green-fluorescence imaging-guided partial resection and sclerotherapy
Microcystic lymphatic B
Partial resection and sclerotherapy
Partial resection and sclerotherapy
Partial resection and sclerotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inflow occlusion with perforation of septation and sclerotherapy
Inflow occlusion assisted by indocyanine green-fluorescence imaging combined with perforation of septation and sclerotherapy
Perforation of septation and sclerotherapy
Perforation of septation and sclerotherapy
Indocyanine green-guided partial resection and sclerotherapy
Indocyanine green-fluorescence imaging-guided partial resection and sclerotherapy
Partial resection and sclerotherapy
Partial resection and sclerotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Days
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tao Han
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weimin Shen, Dr.
Role: STUDY_DIRECTOR
Children's Hospital of Nanjing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's hospital of Nanjing medical university
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NanjingCH011665
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.